Podcasts about centene

On this episode of the STL Bucket List Show, we sit down with Logan Ice, founder of The Growth Den — a Saint Louis-based fractional growth and demand marketing consultancy helping local businesses stop guessing and start advertising with intention.Logan first landed in Saint Louis for Washington University, but it was a $5 scalped ticket to a Cardinals-Cubs game — and a stadium-shaking Pujols walk-off grand slam — that convinced him to stay for good. After a detour to Seattle helping Varsity Tutors open a new office and years consulting for enterprise clients like Edward Jones and Centene, he built The Growth Den around a different model: instead of open-ended retainers, he embeds as a fractional head of growth, builds the tools and AI models a business needs, and then hands them the keys. In this conversation, Logan and Luke dig into the fundamentals every Saint Louis business owner should know — the difference between demand generation and demand capture, where a restaurant with a $500 budget should actually spend it, why protecting your own brand terms on Google comes before anything flashy, and the single biggest mistake he sees business owners make with their ad accounts. It's a conversation about building a business without losing your family in the process — and why, for Logan, the real ROI is never missing bedtime.They discuss: - Why a Cardinals game sealed Logan's decision to call Saint Louis home - Building The Growth Den around an embedded, fractional growth model instead of retainers - The real difference between demand generation and demand capture - Where a local restaurant should spend its first $500 in ad budget - Knowing when it's time to stop DIY-ing your marketing and bring in helpSupport the show

In this episode, Jakob Emerson, Associate News Director, Becker's Healthcare, discusses Centene's exit from the commercial group markets in California and Oregon, rising employer health insurance costs and growing pressure on coverage. He also explores specialty drug spending, AI-driven administrative costs, payer consolidation and the evolving politics of health insurance.

In this episode, Jakob Emerson, Associate News Director, Becker's Healthcare, discusses Centene's exit from the commercial group markets in California and Oregon, rising employer health insurance costs and growing pressure on coverage. He also explores specialty drug spending, AI-driven administrative costs, payer consolidation and the evolving politics of health insurance.

In this episode of The Dish on Health IT, Tony Schueth, CEO of Point-of-Care Partners (POCP), welcomes Angel Ballew, Head of Pharmacy Clinical Programs & Services at Centene Corporation, along with Seth Joseph, Managing Director of Summit Health Advisors, and Jason Reed, Senior Consultant at Point-of-Care Partners, for a discussion about what it will take to scale pharmacist-delivered clinical services. The conversation builds on findings from the NCPDP Foundation-funded white paper, A Business Model Framework to Scale Pharmacy-Delivered Clinical Services, developed with contributions from Point-of-Care Partners and Summit Health Advisors. The research starts from an important premise: there is already significant evidence that pharmacist-delivered clinical services can improve patient outcomes. The harder question is how to make those services operationally and financially sustainable at scale. Tony begins by asking Angel about the role pharmacists can play in closing care gaps, particularly for vulnerable and rural populations. Angel notes that Centene serves approximately 3.5 million people living in rural communities, but emphasizes that access challenges extend beyond geography to transportation, housing, food insecurity, and other social determinants of health. Against that backdrop, pharmacists can be among the most accessible healthcare professionals in a community and may interact with patients more frequently than physicians or other providers. Angel describes opportunities for pharmacists to reinforce medication adherence, identify medication-related concerns, provide immunizations, support test-and-treat services, conduct screenings, and perform other clinical services. As states continue expanding pharmacists' scope of practice and provider recognition, she sees opportunities to further integrate pharmacists into the healthcare team, particularly in communities with limited provider access. Seth and Jason broaden the discussion by sharing what emerged from the stakeholder interviews and industry research behind the white paper. Pharmacist-delivered services are already being piloted or implemented across areas including gaps-in-care counseling, test-and-treat programs, medication counseling and medication therapy management, immunizations and preventive screenings, and chronic disease management. Jason notes that pharmacists can play an important role between physician visits for patients managing conditions such as diabetes and hypertension. The conversation then turns to one of the biggest obstacles to scale: reimbursement and credentialing. Angel describes the tension between generating enough patient volume to make participation worthwhile for pharmacies and demonstrating enough outcomes and value to justify health plan investment. She discusses Centene's work to make credentialing requirements clearer for pharmacy partners, including the internal education required to bring pharmacy into processes traditionally designed around other healthcare providers. Tony asks Seth what the research suggests needs to change. Seth explains that the findings pointed strongly toward health plans and pharmacies working together to lead the development of sustainable models. Pharmacy benefit managers remain important participants with established relationships, networks, technology, and processes, but Seth describes the difficulty an innovative program champion within a PBM can face when they must first secure a client and then assemble participating pharmacies. Health plans may have greater ability to initiate programs and bring the necessary parties together, although their different lines of business and geographic markets add their own complexity. Angel shares how some of this has played out at Centene. The organization has worked directly with pharmacy communities and industry partners, often state by state because of differences in pharmacist scope-of-practice requirements. At the same time, Centene has developed a national program with consistent quality measures and an infrastructure that can support additional pharmacy service opportunities. That experience provides a real-world look at what scaling can require. Angel describes participation approaching 73 percent nationally and nearly 30,000 pharmacies contracted to participate in the program, including growth of more than 10,000 pharmacies over the past several years. She points to consistency as an important part of building participation. Rather than continually replacing programs with something new, Centene has gathered feedback and iterated, helping pharmacy partners gain confidence that the opportunity is stable enough to warrant their investment. The discussion then returns to a central finding of the white paper: the “cold start,” or chicken-and-egg, problem. Pharmacies may hesitate to invest in technology, staffing, workflow redesign, and clinical capabilities until sufficient patient volume exists, while health plans want sufficient pharmacy participation before investing in programs and measuring outcomes. Meanwhile, differences in credentialing, enrollment, reimbursement, contracting, and reporting continue to create practical barriers. Tony introduces the concept of regional Pharmacy Health Alliances for Reimbursable Medical Services, or PHARMS, as one potential approach to addressing the cold-start problem by bringing health plans and pharmacies together within a geographic market. Angel agrees that the concept begins with the right problem. The industry does not lack evidence that pharmacists can improve outcomes or help address gaps created by provider shortages. What remains less aligned is the business model. She cautions, however, that health plan operations vary considerably across lines of business, patient populations, benefit designs, quality priorities, and state Medicaid requirements. A regional model therefore needs enough flexibility to account for those differences. Seth explains that this variation is precisely why the research pointed toward regional collaboration rather than attempting to solve every issue nationally at once. The goal is not necessarily complete standardization, but identifying enough commonality among health plans and lines of business to prioritize a smaller number of services and begin building the infrastructure needed to support them. Angel views those complexities as design considerations rather than reasons not to pursue regional collaboration. She also sees the potential for lessons and common approaches developed regionally to eventually contribute to greater standardization nationally, particularly within individual product lines. Jason brings the discussion back to the pharmacy perspective. Pharmacies need confidence that services will be reimbursed before they can reasonably invest in technology, redesign workflows, train staff, and begin documenting clinical care differently. Regional collaboration among multiple payers could give pharmacies greater confidence that those investments will support sufficient patient volume while creating value for patients, pharmacies, and payers. From there, the conversation moves to another critical requirement for advanced pharmacy practice: data interoperability. Tony points out that pharmacists cannot effectively close care gaps if relevant clinical information remains siloed. Angel agrees that pharmacists need timely, actionable clinical information and enough context beyond the dispensing system to intervene effectively. At the same time, she cautions against overwhelming pharmacists with more information than they can realistically use within their workflows. She also challenges the idea that interoperability must be an all-or-nothing proposition. While the industry continues working toward a more ideal interoperability environment, imperfect data exchange should not prevent health plans and pharmacies from making progress today. Jason expands on the interoperability challenge by discussing the emerging concept of a pharmacy EHR. Pharmacy management systems are highly effective at supporting medication dispensing and claims transactions, but advanced clinical services require additional information. He argues that the answer is not simply to deliver the entire EHR to the pharmacist. Instead, the industry needs to identify the minimum actionable clinical information pharmacists need to make better decisions and perform specific services. Just as importantly, Jason emphasizes that pharmacy interoperability must be bidirectional. Pharmacists increasingly generate clinically valuable information through patient interactions, and that information also needs to reach providers and other members of the care team. Angel notes that Centene already receives some information back from pharmacies, including through programs involving social determinants of health, although the more seamless bidirectional infrastructure envisioned by the group is still developing. Looking ahead five years, Seth describes himself as a “data-driven optimist.” He points to momentum across private-sector organizations, national and independent pharmacies, state governments, and policy initiatives. While significant reimbursement, policy, and infrastructure challenges remain, he believes many of the pieces needed to overcome the cold-start problem are beginning to come together. Angel shares that optimism. Her hope is that pharmacists become a much more integrated and visible part of frontline healthcare delivery. The COVID-19 pandemic demonstrated how accessible and valuable pharmacists can be when the healthcare system needs them, and she sees an opportunity to continue moving the profession beyond its traditional dispensing role. Jason adds that demographic pressures, including an aging population and primary care capacity challenges, will continue creating demand for pharmacists to practice at the top of their licenses. He expects states to continue expanding pharmacist prescribing authority and clinical roles while technology, interoperability, and potentially AI help pharmacies operate more efficiently and support broader clinical services. Tony closes with the question asked of every guest on The Dish on Health IT: what is one habit or perception healthcare stakeholders should change or revisit starting tomorrow? Angel challenges listeners to think about pharmacists as more than medication experts. They are also access experts. In a healthcare system facing provider shortages, increasing complexity, barriers to care, and pressure to improve quality, she encourages healthcare leaders to ask how they can better leverage one of the most accessible healthcare professionals available in nearly every community. Rather than focusing only on what pharmacists dispense, Angel leaves listeners with a broader question: What can pharmacists prevent or help solve? The episode closes, as always, with the reminder that Health IT is a dish best served hot. Prefer video? Catch episodes on the POCP YouTube channel

D-SNPs are offered by private insurance companies (such as UnitedHealthcare, Humana, Aetna, and Centene) that contract with both Medicare and your state's Medicaid program. According to CMS data, D-SNP enrollment has grown by more than 150% over the past five years, making it the fastest-growing segment within Medicare Advantage

No Surprises Act payment disputes continue to rise. Centene raises its full-year financial outlook after a strong second quarter. And the FDA selects the first participant in its digital health pilot program. Listen to these stories and more on today's episode of The Gist Healthcare Podcast. Hosted on Acast. See acast.com/privacy for more information.

In this episode, Angel Ballew, Head of Pharmacy Clinical Programs and Services at Centene, discusses how the organization approaches GLP-1 coverage across Medicaid, Medicare, and marketplace plans while balancing clinical evidence, affordability, and member access. She also shares insights on utilization management, adherence strategies, and preparing for the next wave of indications for these rapidly evolving therapies.

Jill Wener, MD is a board-certified Internist, ICF-certified professional coach, certified EFT/tapping practitioner and trainer, anti-racism educator, DEI consultant, trauma specialist, allyship coach, and expert in physician wellness. Jill is passionate about helping people take responsibility for their problems and teaching them practical, easy, rewarding, and trauma-informed tools to take self-improvement to the next level. Jill is the co-creator of the CME-accredited Conscious Anti-Racism training programs, the host of the Conscious Anti-Racism podcast, and the co-author of the best-selling Conscious Anti-Racism book. She has created CME-accredited EFT/tapping and meditation courses. Jill has worked with clients such as Georgia Aquarium, Dana Farber Cancer Institute, Yale University, the Accreditation Council for Graduate Medical Education, Seattle Children's Hospital, Centene, Santa Clara Medical Society, Rush University Medical Center, ChenMed, the Pittsburgh Business Group on Health, Emory University, Atkins Global, and the National Alliance for Healthcare Purchaser Coalitions.

In this episode, Angel Ballew, Head of Pharmacy Clinical Programs and Services at Centene, discusses how the organization approaches GLP-1 coverage across Medicaid, Medicare, and marketplace plans while balancing clinical evidence, affordability, and member access. She also shares insights on utilization management, adherence strategies, and preparing for the next wave of indications for these rapidly evolving therapies.

Marc Cox and Kim St. Onge discuss the latest on Iran, election integrity concerns, and a foiled terror plot targeting a UFC event. The hour also covers Centene's employee buyouts, the I-44 sinkhole, Manchester Road speed limit debates, the Shaw Park Aquatic Center case, a viral bathroom controversy involving a father and his daughters, and the latest business headlines with Nicole Murray. To wrap the hour, in other news.

Marc Cox and Kim St. Onge tackle the biggest local and national stories of the day, including the Trump-Iran ceasefire and oil agreement, concerns over Middle East stability, the Shaw Park Aquatic Center molestation case, St. Louis infrastructure challenges, and Centene's employee buyout program. Kim's "Kim on a Whim" examines the controversy surrounding Bible verses on San Francisco Giants Pride Night caps and the debate over faith, free expression, and inclusion in sports. Guests include Don Palmer on election integrity, voter rolls, and ballot harvesting; Acting Labor Secretary Keith Sonderling on unemployment fraud, manufacturing growth, and apprenticeships; and John Mack of Pink Tiger Marketing on the new Mark Cox Morning Show moving billboards. In Hour 4, Jimmy Failla discusses the Knicks' championship celebration, President Trump's UFC appearance, and the latest Biden family headlines, while Taylor Riggs breaks down falling oil prices, gas prices, inflation, and global energy markets.

US President Trump is reportedly not satisfied with and is unlikely to accept the Iranian proposal; CNN reports that the US and Iran are not as far apart as they seem.BoJ maintained its policy rate as expected, though subject to a hawkish 6-3 vote split, dissenters highlighted upside risks to inflation. Ueda non-committal on the timing of the next move.European bourses firmer, lifting incrementally after a contained open. US futures are mixed/lower into earnings and after OpenAI missed internal targets.JPY led post-BoJ before retreating and weakening on Ueda, USD firmer to the modest detriment of peers across the board; base & precious metals hit.Energy bolstered by the overnight updates, and as Iran's Foreign Minister is not returning to Pakistan post-Russia.Fixed falters as energy climbs, Bunds hit by the latest ECB surveys, Gilts lag into the Privileges debate regarding PM Starmer.Looking ahead, highlights include US ADP Weekly Employment Change, US House Price Index (Feb), US CB Consumer Confidence (Apr), US Richmond Fed Index (Apr), US Dallas Fed Index (Apr), NBH Policy Announcement (Apr), and speakers include ECB President Lagarde, Supply from the US.Earnings from RobinHood, Bloom Energy, Visa, Booking.com, NXP Semiconductor, UPS, Coca-Cola, Spotify, General Motors, Centene.Read the full report covering Equities, Forex, Fixed Income, Commodites and more on Newsquawk

US President Trump is reportedly not satisfied with and is unlikely to accept the Iranian proposal; CNN reports that the US and Iran are not as far apart as they seem.BoJ maintained its policy rate as expected, though subject to a hawkish 6-3 vote split, dissenters highlighted upside risks to inflation.APAC pressured after the reporting around Trump, Nikkei 225 underperformed after the BoJ's hawkish-hold.DXY initially contained but then ticked higher, JPY benefited from the BoJ; JGBs gapped lower, but the move retraced, USTs rangebound.Crude supported by the reporting from the Situation Room, metals hit by the risk tone, hawkish action, and USD gains.Looking ahead, highlights include Spanish Retail Sales (Mar), Italian PPI (Mar), US ADP Weekly Employment Change, US House Price Index (Feb), US CB Consumer Confidence (Apr), US Richmond Fed Index (Apr), US Dallas Fed Index (Apr), NBH Policy Announcement (Apr), Speakers include BoJ Governor Ueda and ECB President Lagarde, Supply from the Netherlands, UK and US.Earnings from RobinHood, Bloom Energy, Visa, Booking.com, NXP Semiconductor, UPS, Coca-Cola, Spotify, General Motors, Centene, Airbus, Air Liquide, BP & Barclays.Click for the Newsquawk Week Ahead.Read the full report covering Equities, Forex, Fixed Income, Commodites and more on Newsquawk

Why are salty snacks hurting Campbell's shares? And what's ailing Centene stock? Plus, why Petco thinks it can make a profit comeback? Host Xavier Martinez discusses the biggest stock moves of the week and the news that drove them. Sign up for the WSJ's free Markets A.M. newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices

Why are salty snacks hurting Campbell's shares? And what's ailing Centene stock? Plus, why Petco thinks it can make a profit comeback? Host Xavier Martinez discusses the biggest stock moves of the week and the news that drove them.Sign up for the WSJ's free Markets A.M. newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, Dr. Alice Hm Chen, Executive Vice President and Chief Health Officer at Centene, discusses how the organization is improving maternal and child health outcomes across Medicaid, Medicare, and Marketplace populations. She shares insights on rural care challenges, evidence based interventions like midwifery and doulas, and how data and partnerships drive population health impact.

In this episode, Dr. Alice Hm Chen, Executive Vice President and Chief Health Officer at Centene, discusses how the organization is improving maternal and child health outcomes across Medicaid, Medicare, and Marketplace populations. She shares insights on rural care challenges, evidence based interventions like midwifery and doulas, and how data and partnerships drive population health impact.

In der heutigen Folge sprechen die Finanzjournalisten Anja Ettel und Holger Zschäpitz über einen Ritterschlag für Intel, Rebound bei Rüstung und einen Branchen-Deal der Superlative. Außerdem geht es um Apple, Garmin, Thermo Fisher, Boston Scientific, Johnson Health Tech, Planet Fitness, Life Time, Gym Group, Basic Fit, Xponential Fitness, Technogym, Nike, Adidas, Puma, Lululemon, Lockheed Martin, L3Harris, Kratos Defense, Nvidia, Oracle, Apple, Palantir, Bayer, Puma, Tilray Brands, General Motors, Elevance Health, Centene, Cigna, UnitedHealth und Molina Healthcare, Rio Tinto, Glencore, BHP Group, Siemens, Meta und Keller Group. Wir freuen uns an Feedback über aaa@welt.de. Noch mehr "Alles auf Aktien" findet Ihr bei WELTplus und Apple Podcasts – inklusive aller Artikel der Hosts und AAA-Newsletter. Hier bei WELT: https://www.welt.de/podcasts/alles-auf-aktien/plus247399208/Boersen-Podcast-AAA-Bonus-Folgen-Jede-Woche-noch-mehr-Antworten-auf-Eure-Boersen-Fragen.html. Der Börsen-Podcast Disclaimer: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlage-Empfehlungen dar. Die Moderatoren und der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen. Hörtipps: Für alle, die noch mehr wissen wollen: Holger Zschäpitz können Sie jede Woche im Finanz- und Wirtschaftspodcast "Deffner&Zschäpitz" hören. +++ Werbung +++ Du möchtest mehr über unsere Werbepartner erfahren? Hier findest du alle Infos & Rabatte! https://linktr.ee/alles_auf_aktien Impressum: https://www.welt.de/services/article7893735/Impressum.html Datenschutz: https://www.welt.de/services/article157550705/Datenschutzerklaerung-WELT-DIGITAL.html

US President Trump said the meeting with Chinese President Xi will be three hours long before returning back to the US; says things will work out very well with Xi on Thursday.European and US equity futures are mixed; NQ outperforms, boosted by NVIDIA as it nears USD 5tln market cap.USD is firmer in the run-up to FOMC, AUD leads as hot CPI dashes RBA rate cut hopes.Fixed income contained awaiting the FOMC, with a mild bearish bias potentially stemming from positive trade updates.XAU returns back above USD 4k/oz, LME Copper reaches new ATHs amid positive US-China trade optimismUS Pending Homes (Sep), FOMC & BoC Policy Announcements; US President Trump to meet South Korea's Leader, Speakers including Fed Chair Powell & BoC's Macklem, Supply from the US.Earnings from Meta, Microsoft, Alphabet, ServiceNow, Starbucks, eBay, Verizon, Boeing, CVS, Caterpillar, Etsy, Centene, Phillips 66.Read the full report covering Equities, Forex, Fixed Income, Commodites and more on Newsquawk

(00:00-27:33) Jackson wallowed on Saturday. Joined by Gabe DeArmond of Power Mizzou to get his perspective on the disappointing loss in Nashville. Some need a football detox. Yesterday felt like a day of mourning. Pribula's injury and possible return. The defense gave you a chance to win that game. Best Mizzou defense in Gabe's lifetime? Questionable play calls especially on the goal line. Getting Olugbode involved more. Passing game seemed to look a bit better when Zollers came in. The kicking situation. Looking ahead at the remainder of Mizzou's schedule and what to expect. Jim Olive from Auto Loan Pro stops by the studio to talk about an event at Centene this Wednesday.(27:41-50:52) When you hear Mazzy Star, you know somebody's wearing it. Jackson's not ready to give up all hope just yet. Zollers auditioning for next year. Today's a sports equinox. Mt. Rushmore of Mizzou heartbreak in Jackson's lifetime. Lix already paid Jackson for their wager. Carwash Dave got himself suspended. Eating chicken tenders playing St. Andrews. Doug is going as Bud Bunny for Halloween.(51:02-1:05:56) James Carlton in studio. James watched on Saturday by himself but not in the bathroom. Speedy Quis's antics. The college football coaching carousel. Odds on the next LSU head coach.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Season FIVE Episode THREE of the Your Story Our Fight® podcast welcomes Rachel Carmen Ceasar. Rachel Carmen Ceasar is a medical anthropologist and public health researcher committed to helping people make informed health decisions rooted in science and evidence. She holds a PhD in Medical Anthropology from the University of California, Berkeley, and currently serves as an Assistant Professor at the Keck School of Medicine at the University of Southern California, in the Department of Population and Public Health Sciences.Her research focuses on the use of cannabis across women's lifespans, including during pregnancy and postpartum (at the Maternal Cannabis Lab). In addition to her academic work, Rachel is the founder of Culture of Health & Tech, a user experience research consultancy through which she advises health and technology organizations such as Centene, Kaiser Permanente, and Baxter. Rachel is also a lupus warrior and passionate advocate for reproductive health. She is the mother of a 7-year-old and, after experiencing four miscarriages, she turned to extensive research on the intersection of lupus and fertility. With the guidance of her rheumatologist, Dr. Leanna Wise, and the support of evidence-based care, Rachel welcomed a baby boy in 2024 — a journey that continues to inform her advocacy for reproductive health in the lupus community.

In this episode, Michael Carson, President and CEO of Wellcare, a Centene company, shares how his diverse career and mission-driven approach shape WellCare's Medicare strategy. He highlights the unique needs of dual eligible members, the importance of integrated care, and the push to improve consumer experience across healthcare.

In this episode, Michael Carson, President and CEO of WellCare, a Centene company, shares how his diverse career and mission-driven approach shape WellCare's Medicare strategy. He highlights the unique needs of dual eligible members, the importance of integrated care, and the push to improve consumer experience across healthcare.

In this episode, Scott Becker reviews five of the biggest stock declines over the past 52 weeks, including Vivid Seats, Centene, Lucid Motors, and UnitedHealth, highlighting how even major players can struggle despite investor optimism.

In this episode, Scott Becker reviews five of the biggest stock declines over the past 52 weeks, including Vivid Seats, Centene, Lucid Motors, and UnitedHealth, highlighting how even major players can struggle despite investor optimism.

In this episode, Scott Becker examines the sharp downturn of three healthcare powerhouses

In this episode, Scott Becker examines the sharp downturn of three healthcare powerhouses

In this episode, Scott Becker discusses Centene’s steep 9% stock drop following disappointing second quarter earnings.

The 5 things you need to know before the stock market opens today: OpenAI reportedly plans to release GPT-5 next month, Elon Musk's Starlink suffered one of its biggest-ever global outages, Schwab has announced a stock buyback, health insurer Centene stock is plunging after its second quarter report, and the Astronomer HR executive caught on the Coldplay concert kiss cam has left the company, days after the CEO's departure. Squawk Box is hosted by Joe Kernen, Becky Quick and Andrew Ross Sorkin.  Follow Squawk Pod for the best moments, interviews and analysis from our TV show in an audio-first format. 

In this episode, Scott Becker discusses Centene’s steep 9% stock drop following disappointing second quarter earnings.

US President Trump said he spoke with Fed Chair Powell on rates and the meeting was productive, while he noted that there was no tension and he repeated several times that he believes Powell will do the right thing.US Treasury Secretary Bessent said the US is in a pretty good place with China on trade, and he will talk to China about them buying sanctioned oil from Russia and Iran.Thailand's acting PM said escalation and progression of military exchanges with Cambodia is moving towards war.APAC stocks were lower after the mixed performance in the US; European equity futures indicate a flat cash market open with Euro Stoxx 50 futures unchanged after the cash market finished with gains of 0.2% on Thursday.Looking ahead, highlights include UK Retail Sales, German Ifo, US Durable Goods, Atlanta Fed GDPNow, ECB Survey of Professional Forecasters, Earnings from SGS, Rightmove, NatWest, Volkswagen, Eni, Centene, AutoNation & AON.Read the full report covering Equities, Forex, Fixed Income, Commodites and more on Newsquawk

Big news! The Trump4Sale shop next door to the Office of the President, has just issued an exciting new product: “Trump Fragrance.” Yes, it's officially-certified Trump perfume, allowing you and your loved ones to reek of the essence of The Donald—only $249 for a 3-ounce bottle.I wondered, with so much going on, why is he busy hawking perfume? But then I saw nearly every congressional Republican cravenly cave in to White House demands that they approve Trump's truly stinky budget plan. Ah-ha! They are the perfume's target market! Voting to slash food and health care funding for poor families, just so those dollars can be lavished on tax giveaways for millionaires and billionaires, is extremely unpopular. So Trump was offering them an odoriferous spritz.Some will need gallons of it. Not only did they vote to harm to millions of people, but they rushed back to their districts, loudly demanding that the humanitarian disaster they created be fixed by state and local officials.Then, there is Rep. Rob Bresnahan, a rich Pennsylvania Republican. He owned corporate stock in a big Medicaid provider named Centene, but as a legislative insider Rep. Bresnahan knew that Trump's bill would gut Medicaid and crash Centene's stock value. So, he dumped that stock just one week before the House approved the budget. And, yes, after protecting himself, Rob voted for the Medicaid gut job that caused the stock price to plummet.This is Jim Hightower saying… Even one of Bresnahan's Republican colleagues, Brian Fitzpatrick, was appalled: “We need American leaders who are accountable, transparent, and wholly committed to serving the public—not their stock portfolio,” he said, rightly adding that members of Congress “should be banned from trading individual stocks—period.”Jim Hightower's Lowdown is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit jimhightower.substack.com/subscribe

In this episode, Scott Becker analyzes the performance of key managed care companies, highlighting Oscar Health's resilience, UnitedHealthcare's challenges, and Centene's steep decline as rising patient acuity strains the industry.

In this episode, Scott Becker analyzes the performance of key managed care companies, highlighting Oscar Health's resilience, UnitedHealthcare's challenges, and Centene's steep decline as rising patient acuity strains the industry.

Unexpected Rise In Disease and Death Sinks U.S. Insurance Companies- Dr. Chris Martensen and The Face of Immigration Chaos: 300,000 Kids Lost in the Wind to Abusers and Porn Merchants By John Zmirak   Unexpected Rise In Disease Sinks U.S. Insurance Companies  - Peak Prosperity Watch this video at- https://youtu.be/jQS7rFKwKVo?si=V1L6bykndB4fQo6P Peak Prosperity 555K subscribers 18,173 views Premiered Jul 7, 2025 #donaldtrump #news #usanews To watch Part 2 of this video: https://peak.fan/3hcuj9f3 Join the discussion at Peak Prosperity: https://peak.fan/fr5b44er Unexpected rates of sickness (morbidity) has sunk the stock price of a major US health insurer (Centene or CNC).  Maybe now we can finally have an open conversation about the causes? #donaldtrump #news #usanews #stocks #worldnews #educationalvideo   -------------------------------------------------------------------------------------- The Face of Immigration Chaos: 300,000 Kids Lost in the Wind to Abusers and Porn Merchants By John Zmirak Published on July 1, 2025 For article visit-   https://stream.org/the-face-of-immigration-chaos-300000-kids-lost-in-the-wind-to-abusers-and-porn-merchants/   The Face of Immigration Chaos: 300,000 Kids Lost in the Wind to Abusers and Porn Merchants By John Zmirak Published on July 1, 2025 There's one drum I won't stop banging, because it's a righteous call to war: The Left is not a secular, rationalistic, science-driven movement — though for the sake of social prestige and power it still pretends to be. But in fact, it never was. At every point since the invention of the Left/Right spectrum in the fevered, bloodthirsty frenzy of the French Revolution, the Left has been a post-Christian heresy. It's a cargo cult that cherrypicks from the gospels shiny moral sentiments and glittering aspirations, like the work of some mindless magpie. A New Rival Gospel Never mind that Jesus's moral mandates would be literally nonsensical if He was not divine and couldn't offer eternal rewards for self-sacrifice in this life. (Try explaining “Turn the other cheek” to Ghengis Khan and then get back to me; I'd love to hear how that goes. The meek did not inherit the Mongol Empire.) Nor that claims of “equality” among all men only hold up if we mean “in the eyes of God,” since in our own sight we're vastly diverse and manifestly unequal. Even the militantly atheistic, self-styled “scientific” Communist Utopia millions were willing to kill for was cooked up by Karl Marx as a thinly secularized knock-off of the New Jerusalem. Read historian Norman Cohn's authoritative The Pursuit of the Millennium to learn how Marx's program replicated the crackpot claims of self-anointed “prophets” who roused the rabble to murder the priests and pillage the local Jews. But Leftists are born with the same God-shaped hole in their souls as everyone else, so they plunder the Gospel to fill it, picking only the bits and pieces that please them to make a kind of taxidermied replacement Christ fashioned in their own image. These false Christs or antichrists are invariably cast as victims, waved around as banners, and finally used as cudgels … to pummel actual Christians. First the Peasants, Then the Workers The original radical Leftists of the French Revolution held up “the peasants” as the suffering souls for whom they fought — even as the revolutionary government waged a vicious, genocidal war against the real, live peasants of the Vendee region, killing some 300,000 for the crime of clinging to their Church, instead of the fake one the government had set up and imposed on them. A hundred years later, Karl Marx and his movement would claim the international working class as the victims whom they'd champion against the ruthless exploitation of capitalist oppressors. But Marx would fiercely oppose any moderate reforms that would improve workers' real lives, since these might slow down the bloody revolution he needed to impose Communist rule. His followers would fight against any labor unions they couldn't control. Of course, once the Communists seized power in Russia, then other countries, they would enslave the workers and peasants alike, putting them to work in state-owned monopolies, closing their churches, and subjecting them to totalitarian surveillance and persecution. The New Antichrist Idols: “Persecuted” Immigrants The present face of Leftist false religion manifests as a trinity: Diversity, Equity, and Inclusion, and its ersatz Christ figure is the immigrant. Marxists and tribalists paint immigrants as victims of climate change, Islamophobia, and dictatorial governments. Cheap labor globalists depict them as rough and ready workers whose ethic is better than the sullen, spoiled American natives ripe for replacement.   The media, besotted by their new post-Christian creed, like to select which immigrant stories to tell, the better to paint the Trump administration and its backers as heartless, intolerant, ignorant racist bullies. But Trump's team has been clever, having learned from the debacle of 2017, when their efforts to protect child migrants from human traffickers got painted as “separating families” and “putting kids in cages.” So the administration focused its first removal efforts on gang members, rabid antisemites and jihadists, confident that diversity-happy editors and lawless federal judges wouldn't be able to restrain themselves — but would lionize and try to paint as wounded, hapless puppies the worst immigrants on Earth. Poor, Poor Pitiful Jihadis The Left took the bait. Look at the latest “victims” these apostles of counterfeit Christian compassion have decided to paint as martyrs: The equally radical, equally illegal immigrant relatives of the vicious jihadi who used arson to target a Jewish event to aid Holocaust survivors (one of whom he burned to death), Mohamed Sabry Soliman. Mass media can't help themselves. They're too driven by religious zeal: Of course, the facts of the case fall by the wayside in all this jerry-rigged empathy: Collecting Slaves for Sex Traffickers So the Left will go to the wall for privileged, middle-class, jihadi Muslims who blew through their tourist visas and stayed in our country so their patriarch could incinerate Jews who'd escaped the Nazis. You know who the Left won't talk about? The 300,000 unaccompanied minors smuggled into our country and sent to whoever wanted them, with no vetting or DNA tests for alleged relatives. (Joe Biden abolished that.) How are things going for those migrants, who aren't incinerating American Jews? Gateway Pundit gives us a glimpse: A 37-year-old illegal immigrant, Wilson Manfredo Lopez-Carillo, was arrested in Palm Beach County, Florida, for sexually assaulting a 16-year-old girl placed in his home through the Department of Health and Human Services' (HHS) “Unaccompanied Alien Children” (UAC) program. According to the Daily Wire, the arrest was made on May 22, 2025. According to charging documents from the Palm Beach County Sheriff's Office, Lopez-Carillo faces three counts of sexual assault on a minor. The victim, who arrived in the U.S. in August 2023 as an unaccompanied minor, was sent by HHS to live with Lopez-Carillo and others in a loosely vetted household.   Police reports detail a horrifying pattern of abuse, with Lopez-Carillo allegedly taking advantage of the girl's isolation to assault her on multiple occasions in February 2024.   On one occasion, while the adult woman in the household was out selling tamales to support the family, Lopez-Carillo allegedly grabbed the teen in the kitchen, dragged her to his bedroom, and sexually assaulted her.   A second incident followed a similar pattern, with the predator offering the girl $100 to stay silent — an offer she bravely refused. Fearing retribution, the teen initially did not report the assaults, as Lopez-Carillo had threatened her to keep quiet.   Go read the rest, if you have the heart. How many more victims are on Joe Biden's catatonic conscience? We won't know on this side of the grave.   This is the filth, the exploitation, the mass rape that the Left is happy to invite into our nation in order to pose as defenders of “victims” and rack up names for voter fraud. Once again, the group designated as “victims” get victimized for real by those who pretend to defend them.   Leftists haven't just chosen Barabbas. They have tarted him up as Christ.   John Zmirak is a senior editor at The Stream and author or coauthor of 14 books, including The Politically Incorrect Guide to Immigration and The Politically Incorrect Guide to Catholicism. His newest book is No Second Amendment, No First.   Find All of John Zmirak Articles at- https://stream.org/author/johnzmirak/   John Zmirak is a Senior Editor of The Stream. He received his B.A. from Yale University in 1986, then his M.F.A. in screenwriting and fiction and his Ph.D. in English in 1996 from Louisiana State University. He has been Press Secretary to pro-life Louisiana Governor Mike Foster, and a reporter and editor at Success magazine and Investor's Business Daily, among other publications. His essays, poems, and other works have appeared in First Things, The Weekly Standard, The Atlanta Journal-Constitution, USA Today, FrontPage Magazine, The American Conservative, The South Carolina Review, Modern Age, The Intercollegiate Review, Commonweal, and The National Catholic Register, among other venues. He has contributed to American Conservatism: An Encyclopedia and The Encyclopedia of Catholic Social Thought. From 2000-2004 he served as Senior Editor of Faith & Family magazine and a reporter at The National Catholic Register. During 2012 he was editor of Crisis. He is author, co-author, or editor of twelve books, including Wilhelm Ropke: Swiss Localist, Global Economist, The Grand Inquisitor and The Race to Save Our Century. His newest book is No Second Amendment, No First. Zmirak can be found at https://stream.org/author/johnzmirak/   John Zmirak is a senior editor at The Stream and author or co-author of ten books, including The Politically Incorrect Guide to Immigration and The Politically Incorrect Guide to Catholicism. He is co-author with Jason Jones of “God, Guns, & the Government.”   John Zmirak's latest book: No Second Amendment, No First  by John Zmirak  Available March 19, 2024 Today's Left endlessly preaches the evils of “gun violence." It is a message increasingly echoed from the nation's pulpits, presented as common-sense decency and virtue. Calls for “radical non-violence” are routinely endowed with the imprimatur of religious doctrine.   But what if such teachings were misguided, even damaging? What if the potential of a citizenry to exercise force against violent criminals and tyrannical governments is not just compatible with church teaching, but flows from the very heart of Biblical faith and reason? What if the freedoms we treasure are intimately tied to the power to resist violent coercion?  This is the long-overdue case John Zmirak makes with stunning clarity and conviction in No Second Amendment, No First. A Yale-educated journalist and former college professor, Zmirak shows how the right of self-defense against authoritarian government was affirmed in both the Old and New Testaments, is implied in Natural Law, and has been part of Church tradition over the centuries.   -------------------------------------------------------------------- 

In this episode, Scott Becker breaks down the sharp downturn of four major companies over the last 52 weeks, including Stellantis Jeep, Abercrombie & Fitch, Centene, and Moderna.

In this episode, Scott Becker breaks down the sharp downturn of four major companies over the last 52 weeks, including Stellantis Jeep, Abercrombie & Fitch, Centene, and Moderna.

Unexpected rates of sickness (morbidity) has sunk the stock price of a major US health insurer (Centene or CNC). Maybe now we can finally have an open conversation about the causes?Click Here for Part 2

In this episode, Scott Becker discusses NVIDIA's rapid rise toward a $4 trillion valuation, Apple's modest recovery after early-year declines, and ongoing struggles among major healthcare stocks like Centene and UnitedHealth.

In this episode, Scott Becker discusses NVIDIA's rapid rise toward a $4 trillion valuation, Apple's modest recovery after early-year declines, and ongoing struggles among major healthcare stocks like Centene and UnitedHealth.

In this episode, Jakob Emerson, Associate News Director at Becker's, unpacks the political and financial ripple effects of the GOP reconciliation bill. He also shares insights into major concerns for payers like Centene and UnitedHealthcare, looming Medicaid and ACA enrollment losses, and the long-term implications for healthcare access, hospitals, and insurers alike.

In this episode, Scott Becker discusses the Senate passage of a major tax bill now heading to the House for a high-stakes reconciliation, alongside key updates on Centene’s stock plunge, and more.

In this episode, Scott Becker discusses Centene's 40 percent stock drop following its announcement to stop providing financial guidance.

The 5 things you need to know before the stock market opens today: the ADP releases its monthly metrics for private sector hiring later this morning, Tesla will release its own second quarter delivery numbers, health insurer Centene has pulled its 2025 earnings guidance, beverage conglomerate Constellation Brands missed quarterly estimates in its latest report, and Netflix and Spotify could be teaming up on a screen near you.  Squawk Box is hosted by Joe Kernen, Becky Quick and Andrew Ross Sorkin.  Follow Squawk Pod for the best moments, interviews and analysis from our TV show in an audio-first format. 

David Faber and Jim Cramer drilled down on two big stories from the world of mega-tech: Microsoft announced it is laying off about 9,000 employees worldwidein its latest round of job cuts, while Tesla saw its shares rise on the company's Q2 deliveries report. Also in focus: Big banks boost dividends and announce stock buybacks, a negative surprise in the ADP jobs report, Centene shares plummet and drag health insurers lower after the company pulls its guidance, Jefferies upgrades Apple to "Hold," Paramount's $16 million settlement with President Trump, OpenAI CEO Sam Altman vs. Meta's poaching, the group of tech stocks Cramer now calls "MNMs." Squawk on the Street Disclaimer

Another day of jobs data and trade deals: Sara Eisen, David Faber, and Wilfred Frost broke down the latest as the President announces a new deal with Vietnam. Key details, this hour. Plus: Oppenheimer's Chief Investment Strategist gave his take on the action – before the team caught up with Valueworks Founder Charles Lemonides, who discussed his investments in Rivian, Joby, Amazon, and Micron.  Also in focus: a number of huge movers, from Centene shares on pace for their worst day *ever* to new numbers out of Constellation Brands… What investors should know about both names. Plus, the big banks playbook as the group sees gains across the board on the promise of dividend hikes and buyback boosts ahead. 

In this episode, Scott Becker discusses the Senate passage of a major tax bill now heading to the House for a high-stakes reconciliation, alongside key updates on Centene’s stock plunge, and more.

In this episode, Alan Silver, President of Centene's ICHRA-focused Ambetter Health Solutions, joins the Jakob Emerson to discuss the rapid evolution of individual coverage HRAs, why large and small employers are embracing the model, and what it takes for insurers to succeed in this growing space.

On this episode of DGTL Voices, Ed interviews Bruce Lee, a seasoned technology leader with a rich background in financial services and healthcare. Bruce shares his journey from a small village in England to becoming the CTO of Centene. We discuss his passion for music, the importance of curiosity and people in technology, and his insights on bridging the gap between payers and providers in healthcare. He emphasizes the need for kindness in personal relationships and the importance of engaging with the evolving landscape of AI and technology.

In this episode, Jakob Emerson, Associate News Director at Becker's Healthcare, joins Scott Becker to break down developments in the payer world, including Centene's CEO firing amid blackmail allegations and the Medicare Advantage rate hike under new CMS Administrator Dr. Mehmet Oz.